Oncology News | pharmaphorum

News

Merck's Keytruda demonstrates adjuvant use in kidney cancer

Merck & Co has announced interim data from its pivotal Phase 3 KEYNOTE-564 trial evaluating immunotherapy Keytruda for the potential adjuvant treatment of patients with renal cell carci

News

Cancer Research UK spinout Achilles raises $175.5m in IPO

UK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US, raising $175.5 million that will be used to take its personalised T cell therapy for lung and ski

News

Gilead scores US approval for breast cancer drug that wowed ...

Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pay off, as the drug has now been approved by the FDA for triple-negative breast cancer.

News

Artifical intelegence DNA molecule. DNA is converted into a binary code. Concept binary code genome. Abstract technology science, concept artifical Dna, 3D illustration

Novartis expands in radio-oncology again with $1.3bn Artios ...

In its second licensing deal in the radio-oncology area in consecutive weeks, Novartis has agreed a $1.3 billion-plus alliance with UK biotech Artios Pharma to develop precision medicines f

News

Sanofi's Sarclisa gains new US multiple myeloma indication

The FDA has approved Sanofi’s Sarclisa (isatuximab) in combination with a new chemotherapy regimen for advanced multiple myeloma, building on a first approval last year.

News

Pyxis follows Pfizer alliance with $152m fundraising for can...

Fresh from a licensing agreement with Pfizer, US startup Pyxis Oncology has raised a sizeable $152 million in second-round financing led by venture capital groups Arix Bioscience and RTW In

Merck's Keytruda demonstrates adjuvant use in kidney cancer

Cancer Research UK spinout Achilles raises $175.5m in IPO

Gilead scores US approval for breast cancer drug that wowed ...

Novartis expands in radio-oncology again with $1.3bn Artios ...

Sanofi's Sarclisa gains new US multiple myeloma indication

Pyxis follows Pfizer alliance with $152m fundraising for can...

GSK to quit Stevenage for new R&D site in Cambridge

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks